Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Revenue

Oryzon Genomics had revenue of $12.61M USD in the twelve months ending March 31, 2026, up 58.51% year-over-year. In the year 2025, Oryzon Genomics had annual revenue of $12.84M with 68.51% growth.

• Revenue (ttm): $12.61M
• Revenue Growth: +58.51%
• P/S Ratio: 21.22
• Revenue / Employee: $274.08K
• Employees: 46
• Market Cap: 232.07M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	12.84M	5.22M	68.51%
Dec 31, 2024	7.62M	-8.07M	-51.43%
Dec 31, 2023	15.69M	-1.09M	-6.50%
Dec 31, 2022	16.78M	4.70M	38.97%
Dec 31, 2021	12.07M	425.74K	3.66%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error